Understanding the impact of settings of care and the development of chemotherapy-induced nausea and vomiting within a population of commercially insured patients
| Autor: | A. Powers, Claudio Faria, Richard H. Chapman, R.L. Knoth, Timothy J Inocencio, Michael Johnsrud, Barnabie C Agatep |
|---|---|
| Rok vydání: | 2014 |
| Předmět: | |
| Zdroj: | Journal of Clinical Oncology. 32:298-298 |
| ISSN: | 1527-7755 0732-183X |
| Popis: | 298 Background: Research evaluating the impact of different clinical practice patterns according to settings of care and oncology patient outcomes is limited. This study describes chemotherapy-induced nausea and vomiting (CINV) rates in chemotherapy (CT) naïve cancer patients starting CT in a hospital outpatient (HOP) or community outpatient (COP) setting. Methods: Using the Optum Normative Health Information Database, patients with a new claim of CT and ≥1 outpatient cancer diagnosis claim between 1/1/06 – 6/30/12 were identified. Patients with previous inpatient cancer diagnoses, multi-day CT regimens or Medicare/Medicaid patients were excluded. CINV was defined using relevant claims-based ICD-9-CM diagnosis and procedure codes or a prescription claim for antiemetics within days 2-7 of 1st 8 CT cycles or 1st 6 months following the index CT claim. CINV events were evaluated descriptively and using regression models Results: Patients receiving CT in HOP vs. COP were similar in age. Patients receiving CT in COP vs. HOP setting were more likely to be female (78.7% vs. 62.8%), breast cancer patients (66.8% vs. 46.7%), live in the South region (49.7% vs. 44.1%) and have higher baseline healthcare costs (mean $24,950 vs. $24,629) (all p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|